
bioAffinity Technologies Prices $2.66 Million Direct Offering and Private Placement
bioAffinity Technologies Announces $2.66 Million Offering with Concurrent Private Placement bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology firm dedicated to noninvasive cancer detection, has entered into a securities purchase agreement with institutional investors for the sale of 2,048,294 shares…












